US FDA slams delivery patch firm Pocono Coated Products over sub-potent meds

By Gareth Macdonald contact

- Last updated on GMT


Related tags: Pharmacology

The US FDA has criticized Pocono Coated Products' (PCP) efforts to bring its transdermal patch plant in Cherryville, North Carolina into compliance with cGMP standards.

The US regulator outlined concerns about PCP’s remediation plan in a warning letter​ this week, explaining that the firm's plan to address problems identified at the facility during an inspection last October lacks detail.

Foremost among the Food and Drug Administration’s (FDA) concerns are measures PCP introduced to ensure the drug-containing transdermal patch products it makes are checked before being released to customers.

Your ongoing corrective actions included a final inspection form, work instructions, guidance documents, and checklists to assure quality approval before you release product to owners. You did not specify if you were going to test your product prior to release​.”

The FDA said PCP must “describe your corrective action plan to assure satisfactory conformance to specifications for your active ingredients and drug products prior to release​.”

Sub-potent patches

The agency also called on PCP to provide a process validation plan for its transdermal patches. It pointed out that products tested during the inspection were found to be sub potent, which it said is an indication that validation procedures are inadequate.

PCP did not respond to a request for comment ahead of publication.

Related news

Show more

Related products

show more

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Flow Cytometry Services

Flow Cytometry Services

Q² Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Q² Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Related suppliers

Follow us


View more